Compliance Management

FDA Warns Four Foreign Drug Manufacturers

Oct 12, 2016

in-PharmaTechnologist.com

The U.S. FDA has issued four warnings against foreign drugmakers, citing reasons including problems with QC, a non-registered facility, and finished products that “did not contain any of the labeled active ingredient.”

According to an article in in-PharmaTechnologist.com, drug manufacturers include Yangzhou Hengyuan Daily Chemical Plastic from China; Delarange Cosmetics & Healthcare from the Netherlands; Laboratoire Sintyl from Switzerland; and Wallace Cameron International from the UK.

Read the full story